Reproductive Hormones During Sustained Administration of Kisspeptin

NARecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

April 2, 2014

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Fertility DisordersHypothalamic Dysfunction
Interventions
OTHER

Kisspeptin 0.1

"Participants will receive kisspeptin hormone at a dose rate of 0.1nmol/kg/hour via a subcutaneous pump device for 8 days during the early follicular phase of their menstrual cycle.~LH, FSH and oestradiol will be measured on day 1 and 8, at 10minute intervals for 8 hours and on Days 3 and 5 they will have a single blood measurement of the same hormones."

OTHER

Saline

"Participants will receive placebo (saline) via a subcutaneous pump device for 8 days during the early follicular phase of their menstrual cycle.~LH, FSH and oestradiol will be measured on day 1 and 8, at 10minute intervals for 8 hours and on Days 3 and 5 they will have a single blood measurement of the same hormones."

OTHER

Kisspeptin 0.3

"Participants will receive kisspeptin hormone at a dose rate of 0.3 nmol/kg/hour via a subcutaneous pump device for 8 days during the early follicular phase of their menstrual cycle.~LH, FSH and oestradiol will be measured on day 1 and 8, at 10minute intervals for 8 hours and on Days 3 and 5 they will have a single blood measurement of the same hormones."

OTHER

Kisspeptin 1.0

"Participants will receive kisspeptin hormone at a dose rate of 1.0 nmol/kg/hour via a subcutaneous pump device for 8 days during the early follicular phase of their menstrual cycle.~LH, FSH and oestradiol will be measured on day 1 and 8, at 10minute intervals for 8 hours and on Days 3 and 5 they will have a single blood measurement of the same hormones."

Trial Locations (1)

W12 0NN

RECRUITING

Imperial College NHS Healthcare Trust, London

All Listed Sponsors
lead

Imperial College London

OTHER